Focus:

Cancer Center Featured Story 2

Add to Favorites Subscribe Share
fbshare-Cancer Center Featured Story 2

Showing results

110 of 1465
Newswise: Rutgers Cancer Institute of New Jersey Doctors Named Among ‘Tops’ in Oncology Care

Article ID: 716247

Rutgers Cancer Institute of New Jersey Doctors Named Among ‘Tops’ in Oncology Care

Rutgers Cancer Institute of New Jersey

Several physicians from Rutgers Cancer Institute of New Jersey have been named among ‘New Jersey’s Top Doctors in Cancer Care’ by Castle Connolly Medical Ltd. The listing appeared recently in Jersey’s Best magazine.

Released:
23-Jul-2019 12:05 PM EDT
Embargo will expire:
25-Jul-2019 11:00 AM EDT
Released to reporters:
23-Jul-2019 11:05 AM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 25-Jul-2019 11:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

MSK_logo.png

Article ID: 716017

Cracking a Code: Landmark Prospective Study Helps Researchers Better Understand Which MGUS Patients Will Progress to a Multiple Myeloma Diagnosis

Memorial Sloan Kettering Cancer Center

Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS) can convert to high-risk MGUS and progress to multiple myeloma within a five-year window. This research clinically supports recommendations for annual blood tests for all individuals diagnosed with MGUS along with re-assessments of a patient’s clinical-risk status.

Released:
18-Jul-2019 11:05 AM EDT
NEWFredHutch_tm_v_tag_4c_rbg_Clearspace.jpg
  • Embargo expired:
    18-Jul-2019 11:00 AM EDT

Article ID: 715892

New Research Identifies Gene That Hides Cancer Cells from Immunotherapy

Fred Hutchinson Cancer Research Center

A team at Fred Hutchinson Cancer Research Center has identified a gene that could make immunotherapy treatments, specifically checkpoint inhibitors, work for a wider variety of cancer patients.

Released:
16-Jul-2019 1:45 PM EDT
Newswise: Discovery shows how difficult-to-treat prostate cancer evades immune system
  • Embargo expired:
    18-Jul-2019 11:00 AM EDT

Article ID: 715847

Discovery shows how difficult-to-treat prostate cancer evades immune system

University of Texas M. D. Anderson Cancer Center

Discovery shows how difficult-to-treat prostate cancer evades immune system and reports pre-clinical development of novel treatment and potential for combination use with immunotherapy drugs.

Released:
17-Jul-2019 1:05 PM EDT
Newswise: Researchers Find Simple Way to Predict and Prevent Dangerous Blood Clots in Patients Treated for Multiple Myeloma

Article ID: 715939

Researchers Find Simple Way to Predict and Prevent Dangerous Blood Clots in Patients Treated for Multiple Myeloma

National Comprehensive Cancer Network® (NCCN®)

New research in JNCCN from the Hutchinson Institute for Cancer Outcomes Research (HICOR) within the Fred Hutch/University of Washington Cancer Consortium—part of the Seattle Cancer Care Alliance—identifies a simple way to help cancer doctors caring for patients with multiple myeloma to predict blood clots in order to take preventive action.

Released:
18-Jul-2019 9:35 AM EDT
Newswise: $2M in Grants Drives Scientific Exploration of Rare Blood Cancer

Article ID: 715833

$2M in Grants Drives Scientific Exploration of Rare Blood Cancer

Rutgers Cancer Institute of New Jersey

More than $2 million in grants recently awarded to a Rutgers Cancer Institute of New Jersey resident researcher will support examination of potential treatment targets for T-cell acute lymphoblastic leukemia (T-ALL).

Released:
17-Jul-2019 8:00 AM EDT
Newswise: New biomarker-guided strategy has potential for liver cancer treatment
  • Embargo expired:
    15-Jul-2019 4:00 PM EDT

Article ID: 715810

New biomarker-guided strategy has potential for liver cancer treatment

University of Texas M. D. Anderson Cancer Center

A study at The University of Texas MD Anderson Cancer Center discovered a cellular pathway tied to cancer that may be beneficial in reducing side effects and extending duration of immunotherapy in some patients with hepatocellular carcinoma, the most common form of liver cancer.

Released:
15-Jul-2019 10:05 AM EDT
seattlecanceralliancelogo.jpg

Article ID: 715791

Immunotherapy Symposium

Seattle Cancer Care Alliance

On September 19 and 20, 2019, SCCA will celebrate its second Immunotherapy Symposium in Seattle, WA.

Released:
15-Jul-2019 10:05 AM EDT

Education

Newswise: Targeting a Key Protein May Keep Ovarian Cancer Cells From Spreading

Article ID: 715610

Targeting a Key Protein May Keep Ovarian Cancer Cells From Spreading

Penn State College of Medicine

Preventing a protein from doing its job may keep a certain type of ovarian cancer cell from growing and dividing uncontrollably in the lab, according to a new study from Penn State College of Medicine.

Released:
11-Jul-2019 9:00 AM EDT

Showing results

110 of 1465

Chat now!